Trial Profile
Interleukin-1 Blockade in Heart Failure With Preserved Ejection Fraction (HFpEF): a Randomized Placebo-controlled Double Blinded Study (D-HART2)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Anakinra (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- Acronyms D-HART2
- 01 Aug 2019 Primary endpoint (Change in Ventilatory efficiency) has not been met as per results published in the Circulation: Heart Failure
- 01 Aug 2019 Primary endpoint (Change in Aerobic Exercise Capacity) has not been met as per results published in the Circulation: Heart Failure
- 12 Mar 2018 Results (n=31) assessing markers of myocardial strain, presented at the 67th Annual Scientific Session of the American College of Cardiology